Charles River Laboratories | CRL - Beban Penjualan Dan Administrasi





Beban Penjualan Dan Administrasi Perubahan Tanggal
Agilent USD 475M 10M 2026-06
Align Technology USD 462.67M 2.67M 2026-06
Bio-Rad Laboratories USD 212M 400K 2026-06
Bruker USD 238.9M 3.2M 2026-06
Cardinal Health USD 1.62B 115M 2026-06
Charles River Laboratories USD 228.9M 69.47M 2026-06
Cigna USD 3.47B 152M 2026-06
Concord Medical Services Hldg CNY 124.78M 15.58M 2025-12
Danaher USD 2.07B 212M 2026-06
Dentsply International USD 364M 13M 2026-06
Elevance Health USD 10.91B 309M 2025-12
Humana USD 3.36B 614M 2025-03
Illumina USD 273M 1000K 2026-06
Incyte USD 351.73M 23.64M 2026-06
Intrexon USD 10.31M 41K 2024-06
IQVIA Holdings USD 574M 72M 2026-06
Laboratory Of America USD 577.2M 26.2M 2026-06
Lakefront Biotherapeutics EUR 22.5M 13M 2026-06
McKesson USD 2.26B 468M 2026-06
Merck EUR 1.57B 49M 2026-06
Mettler Toledo International USD 263.33M 5.01M 2026-06
Novartis USD 3.24B 101M 2026-06
Pfizer USD 3.41B 496M 2026-06
Quest Diagnostics USD 529M 25M 2026-06
Revvity USD 278.58M 24.69M 2026-06
Thermo Fisher Scientific USD 1.91B 111M 2026-06
United Therapeutics USD 206.7M 50.1M 2026-06
UnitedHealth USD 15.22B 1.44B 2025-09
Veradigm USD 27.28M 5.24M 2022-12
Waters USD 405M 11M 2026-06
West Pharmaceutical Services USD 117.6M 18.1M 2026-06